[Trastuzumab deruxtecan (gastric or gastroesophageal junction adenocarcinoma) – Second addendum to Project A25-128]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018015826
German
Original Title: Trastuzumab deruxtecan – (Adenokarzinom des Magens oder des gastroösophagealen Übergangs) 2. Addendum zum Projekt A25-128
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/g26-02.html
Year Published: 2026
URL for published report: https://www.iqwig.de/download/g26-02_trastuzumab-deruxtecan_addendum-zum-projekt-a25-128_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/G26-02
MeSH Terms
  • Immunoconjugates
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Trastuzumab
  • Antibodies, Monoclonal, Humanized
Keywords
  • Trastuzumab deruxtecan
  • Stomach Neoplasms
  • Esophageal Neoplasms
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.